Expression of a cGMP compatible Lucilia sericata insect serine proteinase debridement enzyme

Biotechnology Progress

Volumn 28, Issue 2, 2012, Pages 567-572

  Pritchard, David I ^a   Telford, Gary ^a   Diab, Miliza ^b   Low, Walter ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b PX'Therapeutics   (France)

Author keywords

Biotechnology; Chymotrypsin; Debridement; Lucilia sericata; Venous leg ulcer

Indexed keywords

ACTIVATED ENZYMES; CHYMOTRYPSIN; CLINICAL TRIAL; CURRENT GOOD MANUFACTURING PRACTICES; DEBRIDEMENT; EX-VIVO; IN-VITRO; LEG ULCERS; LUCILIA SERICATA; REFOLDING; SERINE PROTEINASE; THERAPEUTIC PRODUCTS; WOUND DRESSINGS; WOUND HEALING; WOUND TISSUE;

AMINO ACIDS; BIOTECHNOLOGY; DISEASES; ESCHERICHIA COLI; HYDROGELS; TISSUE;

ENZYMES;

INSECT PROTEIN; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; DEBRIDEMENT; ENZYME STABILITY; ENZYMOLOGY; ESCHERICHIA COLI; EVALUATION; FLY; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOPHYSIOLOGY; VARICOSIS; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; DEBRIDEMENT; DIPTERA; ENZYME STABILITY; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; INSECT PROTEINS; MOLECULAR SEQUENCE DATA; SERINE PROTEASES; VARICOSE ULCER; WOUND HEALING;

ESCHERICHIA COLI; HEXAPODA; LUCILIA SERICATA;

EID: 84859643008     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1516     Document Type: Article

References (18)

1. Telford G, Brown AP, Seabra RAM, Horobin AJ, Rich A, English JSC, Pritchard DI. Degradation of eschar from venous leg ulcers using a recombinant chymotrypsin from Lucilia sericata. Br J Dermatol. 2010; 163: 523-531.
2. Smith AG, Powis RA, Pritchard DI, Britland ST. Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds. Biotechnol Prog. 2006; 22: 1690-1696.
3. Britland ST, Smith AG, Finter WF, Eagland D, Vowden K, Vowden P, Telford G, Brown A, Pritchard D. Recombinant Lucilia sericata chymotrypsin in a topical hydrogel formulation degrades human wound eschar ex vivo. Biotechnol Prog. 2011; 27: 870-874.
4. Harding KJ. The Future of Wound Healing. In: Leaper DJ, Harding KJ, editors. Wounds: Biology and Management. Oxford: University Press: Oxford; 1998: 191.
5. Lewis R, Whiting P, ter Riet G, Omeara S, Glanville J. A rapid and systematic review of the clinical effectiveness and cost effectiveness of debriding agents in treating surgical wounds healing by secondary intention. Health Technol. Asses. 2001; 5: 1-131.
6. Ramundo J, Gray M. Enzymatic wound debridement. J Wound Ostomy Cont. 2008; 35: 273-280.
7. Steed DL. Debridement. Am J Surgery. 2004; 187: 71S-74S.
8. Sherman RA, Hall MJR, Thomas S. Medicinal maggots: An ancient remedy for some contemporary afflictions. Ann Rev Entomol. 2000; 45: 55-81.
9. Church JC. Larval intervention in the chronic wound. Eur Wound Manag Assoc. 2001; 1: 10-13.
10. Dumville JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, Mitchell JL, Nelson EA, Soares MO, Torgerson DJ. Venus II: a randomised controlled trial for larval therapy in the management of leg ulcers. Health Technol. Asses. 2009; 13: 1-182.
11. Schmidtchen A, Wolff H, Rydengard V, Hansson C. Detection of serine proteases secreted by Lucilia sericata in vitro and during treatment of a chronic leg ulcer. Acta Derm-Venereol. 2003; 83: 310-311.
12. Chambers L, Woodrow S, Brown AP, Harris PD, Phillips D, Hall M, Church JC, Pritchard DI. Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol. 2003; 148: 14-23.
13. Horobin AJ, Shakesheff KM, Woodrow S, Robinson C, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol. 2003; 148: 923-933.
14. Horobin AJ, Shakesheff KM, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen. 2005; 13: 422-433.
15. Horobin AJ, Shakesheff KM, Pritchard DI. Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J Invest Dermatol. 2006; 126: 1410-1418.
16. Orsini G, Goldberg ME. The renaturation of reduced chymotrypsinogen A in Guanidine HCl. J Biol Chem. 1978; 253: 3453-3458.
17. Pritchard DI, McKean PG, Schad GA. An immunological and biochemical comparison of hookworm species. Parasitol Today. 1990; 6: 154-156.
18. Cress D, Shultz J. SoftLink™ Soft release avidin resin. Promega Notes Magazine. 1993; 42: 8.